Author

Susanne Kloeker

Observed names: Susanne K. Rhoades, Susanne Kloeker Rhoades

Observed institutions: Eli Lilly (United States), University of Utah, Huntsman Cancer Institute, Vall d'Hebron Hospital Universitari, Vanderbilt-Ingram Cancer Center, The University of Tokyo

OpenAlex ID: A5046051756

Genetic ablation of zyxin causes Mena/VASP mislocalization, increased motility, and deficits in actin remodeling

2006 · Laura M. Hoffman, Christopher C. Jensen, et al. · The Journal of Cell Biology · 166

The Kindler Syndrome Protein Is Regulated by Transforming Growth Factor-β and Involved in Integrin-mediated Adhesion

2004 · Susanne Kloeker, Michael B. Major, et al. · Journal of Biological Chemistry · 164

Members of the Zyxin Family of LIM Proteins Interact with Members of the p130Cas Family of Signal Transducers

2002 · Jinseong Yi, Susanne Kloeker, et al. · Journal of Biological Chemistry · 108

TGF-β inhibitors for the treatment of cancer

2005 · Michael Lahn, Susanne Kloeker, et al. · Expert Opinion on Investigational Drugs · 82

TGF-β signalling-related markers in cancer patients with bone metastasis

2008 · Jose Baselga, Mace L. Rothenberg, et al. · Biomarkers · 66

DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling

2004 · Asmaa Mamoune, Jareer Kassis, et al. · Experimental Cell Research · 51

Phase I Study of the JAK2 V617F Inhibitor, LY2784544, in Patients with Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

2011 · Srdan Verstovsek, Ruben A. Mesa, et al. · Blood · 35

TGF-β Receptor Kinase Inhibitors for the Treatment of Cancer

2007 · Michael Lahn, Brandi Berry, et al. · Springer eBooks · 3

TGF-β1, pSMAD and TGFβ-related markers in Patients with advanced metastatic cancer

2006 · José Baselga, Mace L. Rothenberg, et al. · Cancer Research

Works count: 10

Citation count: 675

H-index: 7

I10-index: 7